What is CMR Surgical?

UK surgical-robotics company (Cambridge; founded 2014) making the Versius modular multi-arm teleoperated surgical robot; FDA De Novo 2024 + Versius Plus 510(k) 2025; >40k procedures ex-US.

Where is CMR Surgical based?

CMR Surgical is based in Cambridge, United Kingdom.

When was CMR Surgical founded?

CMR Surgical was founded in 2014.

What does CMR Surgical make?

CMR Surgical has 1 robot model on the DEPLOY registry: Versius (CMR Surgical builds both physical robots and the AI that runs them).

Where does CMR Surgical operate robots?

CMR Surgical operates 2 verified deployments, including at India, United Kingdom.

Are there any incidents involving CMR Surgical?

1 active incident involving CMR Surgical is on the DEPLOY registry. Each is a sourced, append-only record; retracted incidents are suppressed from this view.

Is CMR Surgical safe?

CMR Surgical has 1 active incident on record in the DEPLOY registry. 1 incident on record (1 serious). Most recent: Apr 2026. Retracted incidents are excluded from this count.

CMR Surgical · DEPLOY

Key facts

Product

Versius / Versius Plus modular multi-arm teleoperated surgical robot.

Gating events

FDA De Novo Oct 2024; Versius Plus 510(k) Dec 2025; gynecology 510(k) pending.

wikidata

wikidata.org

wikipedia

en.wikipedia.org

Deploy Watch

Track CMR Surgical on Deploy.

We notify you when a verified state change lands on the record, not when the company issues a claim.

Track CMR Surgical

Data & sources

Press releases2
News coverage1
Web sources1

4 sources backing this record.View all →

Models (1)

View all models →

Current platform

Versius

CMR Surgical (founded 2014, Cambridge, UK; private) makes Versius, the genuine challenger among surgical-robot startups and the one that has clearly crossed the regulatory gating event. Versius is a modular multi-arm teleoperated soft-tissue robot that is heavily software-driven, capturing telematic, video, and outcome data. It received US FDA De Novo marketing authorization in October 2024, the first such authorization for a multi-port soft-tissue general-surgery robot, followed by an FDA 510(k) clearance for the next-generation Versius Plus on December 18, 2025 with US commercialization on track for 2026, and a pending gynecology 510(k) submitted on April 29, 2026; it has long been CE-marked and commercial across Europe, Latin America, the Africa-Middle-East region, and Australia, with more than 40,000 procedures completed outside the US by company reporting. The registry records it at commercial maturity with an active lifecycle. An important current-state correction: the 2021 roughly $3 billion SoftBank-led valuation story is frozen in time, the company went through real restructuring in 2023 with about 350 redundancies, and it was recapitalized with more than $200 million in April 2025, while reported figures of a roughly $3.1 billion 2025 valuation and a potential $4 billion sale are rumor-tier aggregator claims that are not registered. On AI substance the shipped reality is a data-capture and analytics ecosystem with the surgeon in full control; the physical-AI framing is forward-looking, anchored in a March 2026 NVIDIA IGX Thor partnership to evaluate AI for a future Versius, with no autonomous or AI-assisted intraoperative feature cleared or shipped.

surgicalView model →

Relationships

SSoftBank Vision Fund 2Investor SSoftBank Vision Fund 1Investor CCMR SurgicalCustomer

Current leadership (3)

Massimiliano Colella CEOIR-verified
Mark Slack Co-founder & Chief Medical OfficerIR-verified
Luke Hares Co-founder & Chief Innovation OfficerIR-verified

Founders (2)

Mark Slackcofounderfounded 2014-01-01
Luke Harescofounderfounded 2014-01-01

Safety record

1 incident on record (1 serious). Most recent: Apr 2026.

serious: 1

Most recent: Apr 2026

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Incidents affecting CMR Surgical (1)

CMR Surgical Versius: hand-controller arm went still and console became unrecoverable, forcing open conversion (FDA MAUDE)2026-04-07 · Malfunction

Includes incidents linked directly to this company, to its models, or to deployments of its models or under its operation. Retracted incidents are excluded from this view but remain reachable at their canonical URLs.

Operated deployments (2)

VersiusIndia
VersiusUnited Kingdom

Operator customers (1)

CMR Surgical2 deployments

Recent coverage

CMR Surgical in third-party press

CMR Surgical secures 510k clearance of Versius Plus robotic surgical system

Jun 9, 2026

Peer companies

Intuitive Surgical2 models
Johnson & Johnson2 models
Stryker2 models
Vantis2 models
Asensus Surgical1 model
Auris Health1 model

Financial state

Reporting basis: private_reported
Lifecycle stage: growth
Counterparty risk class: moderate

Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.

Funding rounds (2)

Series D2021-06-01
$600M(reported)
Investors: SoftBank Vision Fund 2 (lead)
Series C2020-11-01
$240M(reported)
Investors: SoftBank Vision Fund 1 (lead)

Regulatory filings (1)

DEN230078fda de novo · us_fdagranted2023-11-21reported
Linked models: Versius

Sources (4)

Common questions

What is CMR Surgical?: UK surgical-robotics company (Cambridge; founded 2014) making the Versius modular multi-arm teleoperated surgical robot; FDA De Novo 2024 + Versius Plus 510(k) 2025; >40k procedures ex-US.
Where is CMR Surgical based?: CMR Surgical is based in Cambridge, United Kingdom.
When was CMR Surgical founded?: CMR Surgical was founded in 2014.
What does CMR Surgical make?: CMR Surgical has 1 robot model on the DEPLOY registry: Versius (CMR Surgical builds both physical robots and the AI that runs them).
Where does CMR Surgical operate robots?: CMR Surgical operates 2 verified deployments, including at India, United Kingdom.
Are there any incidents involving CMR Surgical?: 1 active incident involving CMR Surgical is on the DEPLOY registry. Each is a sourced, append-only record; retracted incidents are suppressed from this view.
Is CMR Surgical safe?: CMR Surgical has 1 active incident on record in the DEPLOY registry. 1 incident on record (1 serious). Most recent: Apr 2026. Retracted incidents are excluded from this count.

Methodology: Claimed (not regulatorily cleared) · 4 sources (2 primary) · last reviewed 2026-06-24

Verification posture

Claimed (not regulatorily cleared)

Cap-flag required

Review state

Drift-flagged

Last reviewed 2026-06-24

1 anchored drift pattern(s); see cap_flags

Sources by quality tier

2: primary-company-ir; Company IR disclosure
1: secondary-trade-publication; Trade publication
1: unclassified; Unclassified source

Cap flags

Claim: CMR Surgical Versius is fully US-pending FDA
Honest status: Versius has De Novo authorization (October 2024, cholecystectomy) and Versius Plus 510(k) clearance (December 2025). Only gynecology 510(k) is currently pending. The wholesale-pending framing is aggregator drift.
Versius is partially US-cleared: De Novo Oct 2024 (cholecystectomy) + Versius Plus 510(k) Dec 2025. Only gynecology 510(k) currently pending.

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Peer companies

Intuitive Surgical2 models
Johnson & Johnson2 models
Stryker2 models
Vantis2 models
Asensus Surgical1 model
Auris Health1 model

In the press

Recent coverage mentioning CMR Surgical from third-party publications. Automatically surfaced; not part of the verified registry record.

AgentReconJun 9, 2026

CMR Surgical secures 510k clearance of Versius Plus robotic surgical system

CMR Surgical received FDA 510k clearance for its second-generation Versius Plus surgical robot for cholecystectomy procedures, paving the way for US commercial launch in 2026.…

↗

Machine-readable surfaces

Markdown mirror: /companies/cmr-surgical.md
RSS feed: /companies/cmr-surgical/feed.xml
JSON-LD: embedded in this page’s head
REST API: /v1/companies/6bbb447e-0278-4ae1-822d-8b546420511e
Revision history: /companies/cmr-surgical/history
Data documentation: /data
Query this programmatically: Deploy MCP

Peer companies

Intuitive Surgical2 models
Johnson & Johnson2 models
Stryker2 models
Vantis2 models
Asensus Surgical1 model
Auris Health1 model

DEPLOY Intelligence Score

28.4/ 100

vs 6 months ago

6-month trend

Peer rankingTop 15% of Surgical

Analysis

Safety profile within acceptable range for category. Limited public visibility and press coverage relative to peers.

Signal flags

New deploymentRecent incidentFunding gap >24mo

Dimension breakdown

Safety Record

78.0MED

Funding Health

37.4HIGH

Deployment Scale

15.5MED

IP Activity

11.6MED

Hiring Signal

0.0LOW

Market Presence

0.0LOW

DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.

Last computed: Jul 3, 2026

Intelligence layer